AstraZeneca PLC Chief Executive Pascal Soriot in media briefing: * CEO says still work to do before laying out future strategy in March * CEO says committed to investing for long-term growth * CEO says company has become too complicated, leading to slow decision-making sometimes * CEO says has 5 existing growth platforms in Brilinta, diabetes, emergingmarkets, respiratory, Japan * CEO says always looking for right business development, acquisitionopportunities * CEO says open to more disruptive or large acquisitions if make sense, butless likely than smaller ones
AstraZeneca PLC (AstraZeneca) is a global biopharmaceutical company. Shares of AZN remained unchanged at $49.81. In the past year, the shares have traded as low as $39.72 and as high as $50.14. On average, 1166490 shares of AZN exchange hands on a given day and today's volume is recorded at 26300.
Source
